Anzeige
Mehr »
Donnerstag, 19.02.2026 - Börsentäglich über 12.000 News
Noch unter 2x Umsatz bewertet - aber wie lange noch?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A4019T | ISIN: GB00BVVK7R18 | Ticker-Symbol:
1-Jahres-Chart
RAPID NUTRITION PLC Chart 1 Jahr
5-Tage-Chart
RAPID NUTRITION PLC 5-Tage-Chart
GlobeNewswire (Europe)
236 Leser
Artikel bewerten:
(1)

Rapid Nutrition Plc: Rapid Nutrition PLC - Strategic Outlook and Near-Term Execution Update

Well-capitalised HealthTech group enters delivery phase across platform expansion, selective acquisitions and science-led product development

LONDON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Rapid Nutrition PLC, a HealthTech company trading on Euronext Growth Paris (ALRPD), provides a strategic outlook update as the Company enters a focused execution phase across its core growth initiatives.

Rapid Nutrition is transitioning from a premium nutraceuticals business to a personalised, platform-led HealthTech operating model focused on evidence-based nutrition and immune wellness. Supported by an established operating portfolio, subscription-led engagement and disciplined capital allocation, the Company is further anchored by recent long-term institutional funding and is well-capitalised to execute.

The Board believes the Company has reached an inflection point, moving from strategy to delivery.

The Company operates a portfolio of science-led wellness brands that generate revenue today and underpin its platform strategy. SystemLS delivers evidence-based nutrition products supported by personalised assessment frameworks. Azurene focuses on immune and preventive wellness through differentiated formulations, including blends originally developed as patented combinations of herbs, with ongoing refinement and expansion across APAC.

In addition, Rapid Nutrition is selectively expanding its product portfolio through licensed, evidence-based ingredients in high-demand functional nutrition categories.

Rapid Nutrition operates a diversified, multi-channel business model across direct-to-consumer, subscription, wholesale, practitioner and strategic partnership channels. As part of its platform-led growth strategy, the Company has entered discussions with a target group aligned with its strategic criteria and is confident in its ability to progress the opportunity in the near term, subject to customary diligence and approvals.

Near-Term Execution Priorities

  • Expansion of personalised assessment frameworks
  • Acceleration of product-led growth in priority evidence-based categories
  • Optimisation of direct-to-consumer and marketplace channels
  • Targeted international expansion across APAC and the United States
  • Progression of selective expansion and consolidation initiatives

The Board remains confident in the Company's growth trajectory and expects the upcoming financial period to reflect meaningful progress across its strategic priorities.

About Rapid Nutrition

Rapid Nutrition is a global HealthTech company dedicated to advancing wellness through evidence-based, personalized nutrition solutions. Leveraging advanced technologies, AI, and scientific research, the company is committed to optimizing nutrition, improving health outcomes, and fostering sustainable, healthier lifestyles worldwide.

Investor Relations Contact:
ir@rnplc.com

Media Contact:
Fairfaxpartners: Fair@ir.fairfax.partners

Disclaimer
This announcement contains forward-looking statements, including statements regarding the Company's expectations, intentions, plans, beliefs or forecasts. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or developments to differ materially from those expressed or implied by such statements. These forward-looking statements are based on assumptions and assessments made by the Company in light of its experience and perception of historical trends, current conditions and expected future developments. Forward-looking statements speak only as at the date of this announcement.

Except as required by applicable law or regulation, Rapid Nutrition PLC undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are provided for illustrative purposes only and are not guarantees of future performance.

This announcement is for information purposes only and does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities of Rapid Nutrition PLC in any jurisdiction. This announcement does not constitute a prospectus, offering memorandum or admission document for the purposes of the UK prospectus regime, Regulation (EU) 2017/1129 (the "Prospectus Regulation"), the U.S. Securities Act of 1933 (as amended), or the rules of any securities exchange or trading venue.

The distribution of this announcement may be restricted by law in certain jurisdictions. Persons into whose possession this announcement comes are required to inform themselves about, and to observe, any such restrictions. Any failure to comply with such restrictions may constitute a violation of applicable securities laws.

Rapid Nutrition PLC has engaged Fairfax Partners Inc., based in Vancouver, British Columbia, to provide investor relations and communications services. The service agreement has an initial term of three months commencing January 1, 2026. In consideration for the services, the Company will pay Fairfax Partners a monthly cash fee of €50,000 plus applicable taxes. Fairfax Partners is an independent third-party service provider. Neither Fairfax Partners nor its principals


© 2026 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.